Outlook Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Outlook Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Outlook Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Outlook Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $680k | 426k | 1.60 |
| 2024-12-31 | $109k | 57k | 1.89 |
| 2024-09-30 | $234k | 44k | 5.34 |
| 2024-06-30 | $95k | 13k | 7.38 |
| 2024-03-31 | $143k | 12k | 11.94 |